March 3, 2021

Previous COVID-19 Infection Is Protective Against Virus, but for How Long?

Evidence is mounting that recovered COVID-19 patients have significant immunity to the virus, although it remains unclear how long that lasts. Find out why authors of a new study believe that information is significant not just for those people but also for public policy and vaccine distribution prioritization. 


BPH Medications Linked to Increased Heart-Failure Risk in Men

Benign prostatic hyperplasia (BPH) is a common condition among older men, and many patients are treated with alpha-blockers and 5-alpha reductase inhibitors. A new study suggests that those therapies, especially alpha-blockers, can increase men’s probability of developing for heart failure, although the absolute risks remain low. Here are more details.

Loss of Smell, Taste Can Linger for Months in Recovered COVID-19 Patients

Pharmacists often are queried on when recovered COVID-19 patients will get their smell and taste back. Results from a recent Canadian study might be disappointing for some questioners. Surveys of healthcare workers who lost those senses during infection suggests the problem can linger for 5 months or longer. Here is more information. 


Amoxicillin-Clavulanate Might Be Safer Option for
Uncomplicated Diverticulitis

Uncomplicated diverticulitis often is treated in an outpatient setting and managed with antibiotics. As pharmacists know, patients most commonly are prescribed a combination of metronidazole and a fluoroquinolone. Find out why authors of a new study suggest that isn’t the best option and why an amoxicillin-clavulanate combination might be safer.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -